Actionable, Practical Instruction for Life Science Professionals Actionable, Practical Instruction for Life Science Professionals

The US Food & Drug Administration (FDA), European Medicines Agency (EMA) and other global regulators require  that employees in the pharmaceutical, medical device and biotech industries are trained to meet compliance standards and have fundamental job knowledge.  The Life Science Training Institute (LSTI), a division of Life Science Connect, has developed curriculum that is impactful, convenient and affordable.

Browse our upcoming medical device, biotechnology and pharmaceutical training courses and start on the path to career advancement!



  • LIVE Online Training: Our courses mix the affordability and convenience of online training with the interactivity of the classroom
  • Custom On-Site Training: Biotech, medical device, and pharmaceutical training tailored to your needs and delivered at your faciity
  • Certificate Programs: Earn a professional certificate in a number of Pharmaceutical, Medical Device and Biotech disciplines
  • Thought Leadership: LSTI is your home for industry news and analysis, white papers and reports, original editorial/content, industry leader profiles and more


  • The 5 Basic Tenets Of Data Integrity — And How Failures Occur

    It amazes me that, with all the data integrity issues highlighted in regulatory agency inspections over the last several years, very few people I talk with today are familiar with the court case that set the legal precedent for data integrity standards.  To me, this is one of the reasons why we see so many data integrity issues — those who forget the past are condemned to repeat it.

  • Accelovance Addresses CRA Shortage With Accelovance Academy Inaugural Graduation Class

    Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in vaccines, oncology, and general medicine clinical research held a graduation ceremony yesterday for Accelovance Academy's inaugural class of Clinical Research Associates (CRAs).

  • FDA’S 3D Printing Draft Guidance Leaves Much Unresolved, Even More Unknown

    3D printing of medical devices will revolutionize and disrupt healthcare as we know it. The U.S. Food and Drug Administration (FDA) has already cleared more than 80 medical devices and one prescription drug that are produced by 3D printing techniques.

  • Human Error: How To (Accurately) Identify & Address It Using Performance Models

    After giving a recent course on reacting to human error, one of the attendees sent me a variety of questions about how to apply the human performance models we discussed in FDA-regulated environments.

  • Merck Changes The Paradigm On Clinical Trials

    Patient centricity remains a hot topic in the clinical space, and generated a significant amount of discussion at the CROWN Congress in Philadelphia earlier this year. Few would argue this will be a critical factor in turning around patient perceptions of the pharma industry, and hopefully solve the patient recruitment and retention issues that have long plagued the industry.

More From LSTI Headlines


Best Practices in CMC Dossier Preparation – Facing Tough Challenges July 28, 2016
Special Time for EU and US Participants - 10:30am-12pm EDT, Online Training
Preparing for - and Surviving - a FDA Medical Device Inspection July 28, 2016
1pm-2:30pm EDT, Online Training
Root Cause Analysis for GCP – A Risk Action Plan Guide August 2, 2016
1pm-3pm EDT, Online Training
Aseptic Processing: Preparing Staff and Programs For Compliance August 4, 2016
1pm-2:30pm EDT, Online Training
FDA Guidance on Social Media: Questions Answered and Unanswered August 10, 2016
1pm-2:30pm EDT, Online Training
More Upcoming Courses